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Tretinoin (0.1 % Retin-A cream) was topically applied to 
human cadaver skin in vitro using Franz diffusion chambers. 
The photo-isomerization of tretinoin and retinoic acid per-
cucaneOU5 absorption in the absence of metabolic activity 
were assessed with and witham ambient light exposure to the 
skin. Using HPLC, UV, and GC/MSD, a retinoid exhibiting 
identical chromatographic and spectral characteristics of IS0-
tretinoin was observed in the samples from the skin exposed 
T he r~tinoic acid trecinoin is used extensively as a topi-cal treatment for acne and has recently been described as being dfective tn the treatment of photoaging ill. An important but often overlooked characteriS[ic of rerinoids is their pcop<:nsiry for photo-isomerization 
and photo-degradation. Light elCposure induces the formation of 
several isomers of trctinoin as well as nOll-retinoid producu [2.3]. 
One such isomeric analog of tretinoin (all-trans retinoic acid) is 
isotrctinoin (13-cis retinoic acid), which also has importanr clinical 
utility. The isomerization of cretinoin attribut~d to light ~xposure 
following topical applicacion [0 skin has oOt been previolls ly re-
ported. 
Because isotrerinoin demonstrates topical activiry similar to rhat 
of tretinoin [4,5], we measured the formation of isocretinoin from 
topicaHy applied tretinoin with and without surfacr-light exposure. 
In addition, the percutaneous absorption oftrerinoin and isorrctin-
oin W3S quantified in an in vitro human skin diffusion mooel (6.71. 
METHODS 
Nine cadaveric upper leg skjn dermatome a1lografrs (ages ranging 
from 28 to 63: eight caucasian, one black; four femaJe, five maJe). 
preserved at _70°C. were rapidly thawed at 35°C, rinsed in water, 
and mounted in duplicate on Franz diffusion chambers (Crown 
Glass, Somerville, NJ) with 1 cm l of availab le skin surface area. The 
lower chamber ha.l{..cell was p.1.inted black to exclude light and 
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Abbreviations: 
EI: electron impact 
GC/ MSO: gas chromatography / m-ass selective dettctor 
HPLC: high pressurt' liquid chromatography 
Im/ m2: lumens per square meter 
m/ e: mass/ electron ch:.arge 
mW /cm2; milliwatts per squarc centimeter 
SIM: single ion monitoring 
UV: ultraviolet 
to light, but was vi rtually absent in tbe skin samples main-
tained in the dark. From a single topical appl ication oftrctin-
oin. isotretinoin was as abundent as tretinoin in the chamber 
receiver sol ution, dennis, epidermis, and on che skin surface 
at 24 h aft.er topical application. The data suggest the possibil-
ity chat isorretmoin may have an important role in the phar-
macology of topically applied tretinoin. ] IIII''''' Dermawl 
93:595 -599, 1989 
filled with 5 ml phosphate huffered saline (pH 7.3) containing 0.5% 
Volpo (PEG-20 oleyl ether, Crod, Inc, NY) and 0.5 mg/ m1 ascor-
bic acid. {Volpo. a non-ionic surfactam, incre3ses the solubility of 
hydrophobic compounds in the aqueous based solutions used in 
permeation srudies (B}. It was used here to insure that the diffusion 
of the retinoids from (he skin into the chamber solution would nor 
be inhibited by their poor water solubility. Ascorbic acid was added 
to minimize retJnoid oxidation.) The chambers were maintained at 
37 ~ C, producing a sk.in surface temperature of 30-32°C. Sections 
from four skins were. maintained in the dark throughout the expo-
sure period. 
Sections from all nine skins had a constanr surface exposure of 
lx10l Im/ m2 (approximately 0. 16 mW/ cm2) iJlumination from 
twO visible specttum 20 W fluorescent cool-white rubes (Sylvani.a) 
placed 40 cm above the chambers and lic during the first 12 h of each 
~xpcriment. Retin-A cream (0.1%) (Onho Pharmaceutical Corp. 
Raritan, NJ, Lot #l7E804A) was appli.ed to the skin surface on each 
ch4.mber by a wood applicator weighed befote and after 4.pplication. 
Mean application to each ofthe skin samples was 9.67 ± 0.36 mg 
(n=26) per chamber. Chamber receiver solution was collected and 
replaced with fresh solution at 6. 12, and 24 h after application in 
the light exposed experiments and at 24 h from the dark control 
experiments. 
At 24 h the surfac~ of the skin was washed twice with 0.5 ml 
applications of isopropyl alcohol [Q recov~r the remai.ning surface 
dose . and the epidermis was gently sepauted from the dermis .with 
needle-poim forceps. The isolated dermis was then finely 'mn.ced 
with scissors. Retinoids were extracted from the chamber receiver 
solutions, and the separated epidermis and dermis samples by the 
addition of 1 ml 1 N HCI, 10 ml methylene chloride containing 0.1 
mg/ ml hutylated hydroxy toluene and an intemal standard (acitre~ 
tin; Ro 10-1670). After mixing and cenrrifugation. the organic 
phase was recovered and evaporated under dry nitroge~. Sa~ples 
were reconstirured in 100,uJ isopropyl alcohol for quantlficatlon by 
high-pressure liquid chromatography (HPLC). The surface wash 
was analyzed directly without extract ion or the internal standard. 
All samples were collected in aluminum foil wrapped tubes and 
processed in the dark with only a distant 15 W yellow tungsten 
lamp as 4. light source. 
Four of the nine skins received topical applications of 0.1% 
Retin-A cream, which h4.d 2 tracer amount of lH_(l1.1 2 tetraen) 
0022-202X/ 89/ S0J.50 Copyrighl @ 1989 by The. Society for Investigative Dernutology. Inc. 
595 
596 LEHMAN AND MALANY 
trctinoin added (10 mCi/ mmol final specific activiry, > 99% radio-
label puriry confirmed by HPLC). DuplicatC' chamber sets were 
placed in the dark and under light exposure. Samples were collected 
as previously described. One milliJiter of each chamber receiver 
solution was mixed with 10 ml scintillation Auid and assayed for 
isotope content. Fifry microliters of each surface wash was mixed 
with to m1 of scintillation fluid and counted. The remaining por-
rion of each sample was then processed for HPLC analysis as pre-
viously described. 
Retinoid quantification was by reverse phase HPLC (Table I) 
using peak area normal ized to the internal standard with extracted 
retinoic acid standards. Surface wash samples were quantified di-
recdy by peak area to unext[3cted standards dissolved in isopro-
panol. The minimum detection limit was 2 ng with linear standard 
curves measured to 10 mg from 35.u1 injections. In addition. the 
column eluate flow. after passing through the HPLC's UV-dctec-
tor. was directed into a Radiomatics (Tampa, FL) Flow-One on-line 
scintillation counter to moni tor isotope content of each peak. Unla-
beled retinoid standards and purified 3H-tretinoin and l·C -isotre-
rinom (6. 1 mCi/ mmole) standards were used to determine peak 
dut.ion times. (Radiolabeled and unlabeled tretinoin, isotrctinoin, 
and aci trecin were generous gifts from Hoffmann-La Roche. Nut-
ley. NJ.) Resuhs from [he duplicate skin sections from each skin 
were averaged. and the means among skin were calculated. Staristi-
cal analysis was by Student's (-test. 
Following rerinoid quantification, the- remnam HPLC samples 
from each chamber/skin compartment (Eg receiver solutions to-
gethe r, dermi together. etc.) were combined. preserving the distinc-
tion between ehe dark and ligbt experiments. After evaporating the 
isopropanol. methyl ester derivatives were formed using diazo-
methane in ether by rhe merhod of Fales et al [9]. The products were 
evaporated under dry nitrogen and redissolved in 50,ul isooctane 
(rom which 5,u1 were injected into a Hewlett-Packard (Avondale, 
Penn) capillary gas chromatograph coupled to a mass selective de-
tecror (GC/ MSD) , as described in Table 1. Both single-ion moni-
mring (SIM at m/ e 314) and coral-ion monitoring chromatography 
were performed. Elution times and peak fragmentation spectra were 
compared to isorretinoin and trerinoin methyl derivative standards 
(merhyl retiDoates) prepared in an identical manner. 
In addition, the methyl rerinoates were subjected to a second 
HPLC system (T able I) using a diode array detector monicoring 
350,360 nm, and peak selected spectra scans across 210-500 nm. 
Again, elution times and ultraviolet spectra were compared to the 
known standards. 
RESULTS 
T o identify isotretlnoin from other isomers of retinoic acid three 
dillerem chromatographic separation techniques were used. to-
ger il er with isotopic, mass, and UV spectroscopy. Figure 1 shows 
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chromatographs of the eluting peaks and retinoid standards ob-
tained from a surface wash. The peaks designated as isotretinoin and 
trctinoin in the samples had elution times identical to their retinoic 
acid standards by the first J-IPLC method. AJI samples demonstrated 
peaks at correct elurion times when monicored by SIM at m/ e 314 
by GC/ M SD. Clear total-ion fragmentarion spectra of the methyl 
retinoates in rhe surface wash and in epidermis matched the rerin-
oate standards {mass ion at mle 314, with characterisric ions at m/e 
299.255. 185.177.159. 11 9. 105,91.and41)andwereconsistent 
with published spectra [10,11]. 
The HPLC method used for sCRaration of the mer.hyl retinoates 
was adopted from McKenzie et all3], who demonstrated the separa-
tion of 7 methyl rerinoate isomers. Our data showed three distinct 
peaks and two minor peaks between 11 and 15 min (Fig 1), which 
exhibited characteristic ultraviolet spectral patterns of the methyl 
retinoares. In addition. residual underivitized retinoic acids were 
observed between 8 and 11 min. The numbered peaks in Fig 1 had 
elution times and ultraviolet spectra of the retinoic acids (UV rn..u at 
350-355 nm) and of the methyl rerinoates (UV .,..... at 360-365 nm) 
that were identical to their corresponding standards. 
The analysis of the distribution and occurrence of tretinoin and 
isorretinoin in (he chamber receiver solution. dermis, epidermis. 
and surface wash 24 b after Retin-A app lication are shown in T able 
11. Isorretinoin was as prevalent as tretinoin in all the compartments 
measured from the light exposed skin chambers and was detected 
even within the rust chamber receiver solurion samples (6 h). Com-
pared to the skins maintained in the- dark. th e total amount of rretin-
oin that penetrated the epidermis was diminished by surface- light 
exposure (p < 0 .01). but the total epidermal penetration as [etinoic 
acids (tret inoin plus isotre ti noin) was not statistically different . Iso-
tope content of the chamber receiver solutions 24 II after the topical 
application was 0.77% of the applied dose in the dark and 0.67% in 
the light exposed chambers. From the light exposed skin samples at 
24 h. 25.0 ± 2.0% of the applied dose was measured as tretinoin and 
37.8 ± 4.6% as isotretinoin by HPLC. HPLC of the light exposed 
skin cxperiment samples clearly showed that radiolabel co-eluted 
with isotrerinoin and tretinoin standards (Fig 1). Ninety-eight per-
cent of tbe radiolabel was recovered from these same chambers; 
hence. the unaccountable tretinoin dose (37%) must be other 
photo-degradation or oxidation products, the majoriry of which 
remained on the surfacC' of the skin. The HPLC samples from the 
dark controJ chambers demoTlStrated 98% tretinoin recove,ry with 
only 2% as isotretinoin (blank samples spiked with tretinoin stan-
dard showed no more than 1 % conversion to isotretinoin which 
could be attributed to sample handling and processing). Toral iso-
tope recovery from the dark chambers was simi lar to that from their 
light exposed counterparts (98.1 %). The ratio of isocretinoin to 
tretinoin as methyl rctinoates and radio label observed by HPLC and 
GC/ MSD conErmed thc quantitarive HPLC findings of the reti-
noic acids (average ratio of isotretinoin to trctinoin was 1.7 : 1). 
Table l. Chromatographic Methods Used for Analysis of Tretinoin and lsotretinoina 
HPLC method 1 GC/ MSD H PLC method 2 
Column e lll Resolve (Waren) DB-5-30W (J&W Sc;entific) C l8 Ultrasphere (Altex) 
Size 5mmX15cm 0.2 mm X 30 m 4.6 mm X 25cm 
Tempt~n.rure 25· C 3 min at 180°C then 220· C 40· C 
Solvent 50% Methanol Helium 95% Methanol 
25% Acetonitrile 4.5% H2O 
25% Aqueous Buffer (2.5% ammonium 0.5% Acetic acid 
acetate and 0. 1 M maleic acid) 
Flow rate 2.0 ml/ min 5 psi (at colul11 head) 0.5 ml / min 
Detection UV at 350 mn SIM :n mle 3 14 UV at 350 nm 
EJ mass m/e 40-400 UV at 360 nm 
UV scan 210-500 nm 
S)'stem Waters Hewlett-Packard Hewlett-Packard 
5890/ 5970 1090 
• GC/ MSD .md HI1LC Me-thO<! 2 were- used to analyze the- methyl rl':ti noat~. All Te-.:.genu wc-re HPLC grade or ~ncr. 
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Figure 1. C hrom:uogr:l.phs £rom :I. surface w:l.sh s2mple Obt2ined by the methods outlined in T2ble J 2nd text. Stand2rds were" r2diol2beled 2nd unbbded 
isotrcrinoill 2nd trctinoin and their methyl deriv2tives. Light :md Dark refer to the slcin surf2ce exposure during rhe 2bsorption experiments. The Intern21 
st:lndud (acitret in) . nOt shown here. eluted at 6.5 min by HPLC method 1. Peal number label s: 1, isotretinoin: 2, crerinoin; 3, isorretinoin methyl ester, 4, 
trctinoin methyl ester. 
DISCUSSION 
W e have shown that new compounds develop from rrerinoin when 
Retin-A cream is applied topically to human skin in vi tro while 
being exposed to ambient fluorescent light. This was demonstrated 
by the ahundam appearance of radiolabel in new peaks that arose 
from the radiolabeled tretinoin. This was not unexpected. because 
others ha ve- demonstrated that photo-isomerization and photo-deg-
radation of rerinoids is a function oflight in tensity and duration [21 
and may be influenced by the vehicle (solvent) [12J. However. pre-
vious in vitro isomerization studies have used very intense UV radi-
.uion sources into neat vehicle solutions of rerinoids to obtain dra-
marie photo-degradation results for quantiracive chemicaJ analysis. 
The observations from rhose studies cannot be extrapolated to pre-
dict retinoid degradation in the complex ropical vehicles used c1ini-
calJy at the low ambient room light conditions most frequentl y 
encountered by the skin . The closest analogy to topical conditions 
was reported by Elbaum [13J. who illuminated retinoic acid forfllu-
lations in plastic dishes with fluorescent lights. He reported tbe 
appearance of new peaks with similar retenrion times as isotrerinoin 
and rretinoin by HPLC without funher identi fication. To a much 
lesse-r extent. isomerization of rerinoids may occur in the absence of 
light as a result of metabolic 114J and nonenzymatic reactions [15J. 
Because tbe differem isomeric fonns of retinoie acid (other than 
13-cis and all -trans) are difficult to obtain or are not available for use 
as standa rds. we con6.rmed the identification and isolation of isotre-
tinoin by using several different chromarographic and spectral tech-
niques. 9-cis rerinoic acid was also available and was clearly resolved 
from both isotrerinoin and trerinoin with all rhree chromatographic 
methods. When observed in the samples, it accounted for less than 
t % of the detectable retinoic acid isomers (data nor shown). The 
compound isolated from the skin samples thar we are designating as 
isotretino in demonstrated the same elution rime. UV sIXctra, and 
mass spectra as our known isotretinoin sr311dard in both the acid and 
methyl derivative forms. This peoak was also the moSt abundam new 
compound observed. Although not unequivoca ll y proven. aJi data 
Table n. Distribution of Tretinoin, lsotretinoin. and Radiolabd (lH) from the mean topical applia tion 
of 9.67 mg/ cm2 0.1 % Retin-A cream (9.67 Ilg tretinoin)a 
Without Ligh t Exposure With Light Exposure 
Sample Source Tretiuoin isot'retinoin IsotoIX' T~tinoin 1s0ltetinoin ]SOtO~ 
Receiver Solution (Cumulative) 
6h nd nd nd 0.02(0.02) 0.04(0.02) nd 
12 h nd nd nd 0.03(0.02) 0.06(0.03) nd 
24 h 0.18(0.01) 0(0)" 0.77(0.31) 0.13(0.03) 0.28(0.09) 0.67(0.19) 
Dennis 0.67(0.28) 0.05(0.05) nd 0.11 (0.04) 0.14(0.05) nd 
Epidermis 1.83(0.19) 0.08(0.03) nd 1.89(0.50) 3.75(1.04) nd 
Surface 96.2(2.4) 1.88(0.57) 98.0(3.0) 23.2(1.6) 34.4(3.5) 98. 1 (3.3) 
T Ot21 Recovery 98.8(2.6) 2.0 1(0.51) 98.8(3.1) 25.0(2.0) 37.8(4.6) 98.8(3.3) 
• Values ;tte the mc:;tn (;tnd SE) percent of :lpplied dOSt' with ;tnd withom surf;aC(' Ilghl uposure. Euh lil.:.i ll wuc.umincd in dupliCltc: tin],; II, 4 human skin; light n. 9 human skin: 
nd. not done. a<U'erisk. below limits of dct« tion. 
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s~p~rt the identification and chromatographic isolation of isotre-
nnom. 
The total isotope recovery accoums for the presence of all the 
applied dose. even though only 63% of the light exposed dose' was 
identifiable as isorrerinoin and tretinoin by HPLC. The amount of 
tretinoin remaining was idemical to that observed by Elbaum (25%) 
under similar fluoresce'llt light conditions when the vehicle was 
placed on a plastic dish [13J. However, Elbaum found 60% isorre-
tinoin and 15% of the dose as other products, whereas we observed 
the production of 38% isotretinoin, suggesting that contact with 
the skin may influence the product formarion from photo-degrada-
tion. The remaining 37% could either be orher isomeric analogs of 
tretinoin (e.g., 9-cis. 11-cis, di-, and rri-cis rerinoic acid isomers). 
photo-degradation products. or oxidation products of retinoic acid. 
Some of these' other compounds were observed (but not identified) 
in [he chromatographs as separated peaks that de'monstrated mass 
and UV spectra similar to retinoic acids. Others. if present. we're not 
detectable at the monitored HPLC wavelength (350 and 360 nm). 
not retained on the columns by HPLC or Ge, or not extractable in 
methylene chloride. The slightly higher isotope content of the 
chamber receiver solutions than quantified retinoid content may 
have resulted from (he penetration of radiolabeled water or vehicle 
components as a resul t of tritium exchange. or the penetration of 
trerinoin degradation products not extractable by the methylene 
chloride. 
The percutaneous absorption of tretinoin observed in this study is 
similar to that reported elsewhere [16,17,181, discounting vehicle 
and skin source differences, where only the penetration of rretinoin 
was examined. The simultaneous percutaneous penetration of bath 
retinoic acids. by the appearance of isotretinoin in early chamber 
receiver solution samples and the finding of bath isorretinoin and 
treonoin in epidermis and demus. suggests that isomeric conversion 
occurs rapidly- a UIing exposure to light. Isomeric interconversion 
may also be occurring within the skin as a result oflight penetration 
through the stratum corneum. Simple chemical conversion (000-
mctabolic) may have only a fractional contribution. as suggested by 
the trace presence of isotretinoin detected in the dark control sam-
ples. 
Froz.en skin was specifically used in this study to allow the evalua-
tion of retinoic acid photo-degradation and penetration without the 
confounding issue of concurrent tissue metabolism. Although skin 
that has been frozen may still possess res idual enzymatic activity. it 
does not demonstrate cutaneous metabolism as with fresh viable 
skin [19J. Because our experiments demonstrated virtually no con-
version of tretinoio to isotretinoin or other products in the absence 
of light. metabolic enzymes that may be present had inconsequen-
tial activity. Thus the data supports effective isolation of the opera-
tive conversion mechanism or catalyst to light alone. 
That metabolic activity is important has been reported by Connor 
and Smil [20]. They have shown thac tretinoin. but not isotretinoin. 
is formed in the skin of the hairless mouse' following topical appli-
cation of all-trans-retinol when the mice were kept in the dark 
during the exposure period. They suggest that isotretinoin is not 
formed enzymatically in tbe skin f.rom either topical rretinoin or 
retino l. In support of Connor and Smit, studies in skin metabolism 
of retinoids will require strict elimination oflight exposure to insure 
that the correct assignment of metabolites are to cellular activity 
rather than to photO-degradation pathways. However. one must be 
cautious in attributing appearance in [he skin of a rerinoid and its 
metabolites to an observed dermatologic response without also con-
sidering the contribution of concurrent photo-degradation products 
which will OCCUr in a clinical environment. 
The consequences of systemic exposure to topical rerinoids will 
be a function of both the penetration of photo-degradation products 
and simulrancous metabolic processes. Many published in vivo ani-
mal studies have reported that sytemic reunoic acid metabol ites are 
found in both all-trans and 13-cis forms after the administration of a 
single retinoid isomer species [21 .22 for example]. Depending on 
the isomeric form of the administered parent retinoid, the metabo-
lite ptoduct profiles differ even though shared pathways are as-
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sumed f21,231. Systemic exposure profiles cannot be inferred from 
these studies when there is a simultaneous illtroduction of several 
isomets (e.g .. from photo-degradation with subsequent penetra-
tion) where competition for the same metabolic pathways will 
occur. 
The implications of photo-degradation of retinoic acid to other 
active retinoids as well as many undefined products has not been 
carefully investigated. Photo-isomerization clearly represents a 
complicating factor to our understanding of the pharmacology and 
toxicology of reeinoids in the skin. What is/an:. the active compo-
nen.t{s)? Does toxicity reside more in one isomer or component than 
anoeher. and can toxicity be separated from efficacy? 
Given that it is impossible to conduct long-term clinical trials in 
the dark or control the amount and type oHight exposure, unambig-
uous results will likely never evolve from human clinical trials. 
Animal and in vitro studies offer the best approach to defining the' 
activity of specific retinoid isomers. However, even in these studies 
one must be cognizant of the importance of photo-isomerization 
and photo-degradation and the need to control li gh t exposure. 
Given that lighr exposure has nOt been precisely controlled in most 
past studies. one wonders how the observations and conclusions 
may have been affected by retinoid phocolabiliry. 
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AMERICAN CONTACT DERMATITIS MEETING 
At the annual meeting of rhe Amc:ric;m Academy of Dermarology in 1988. the American 
Contact Dennariris Sociery (ACDS) was established. The group will foner inrerest and 
communication in the field of contact dermatiris. 
The American Comact Dermatitis Sociery will have its first meeting immediately befofe 
rhe annuaJ AAD meeting in San Francisco on Friday. December 1. 1989. The meeting will be 
a forum to prescnr information on new allergens. in depth reviews of older allergens. and to 
learn where and how materials may be obtained. 
Resident pan:jcipation is encouraged. and The Alexander A. Fisher Resident Award will be: 
given to (he bcsr paper presented by a resident at the meeting. 
Applications for membership in the ACDS and infonnation about the meeting may be 
obtailled by writing to Robert L. Rietschel. M.D., Department of Dermatology, Ochsner 
Cl inic. 151 4 Jefferson Highway, New Orleans, LA 70121. 
